BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11585425)

  • 1. Metastatic uterine papillary serous carcinoma to the pericardium.
    Ramirez PT; Ramondetta LM; Burke TW; Gershenson DM; Brewer MA
    Gynecol Oncol; 2001 Oct; 83(1):135-7. PubMed ID: 11585425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uterine papillary serous carcinoma presenting as distant lymph node metastasis.
    Ng JS; Han AC; Edelson MI; Rosenblum NG
    Gynecol Oncol; 2001 Mar; 80(3):417-20. PubMed ID: 11263944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Papillary serous adenocarcinoma of the ovary diagnosed after malignant pericardial tamponade and embolic stroke.
    Winter WE; Seidman J; Krivak TC; Pujari SG; Boice CR; Carlson JW
    Gynecol Oncol; 2002 Mar; 84(3):453-5. PubMed ID: 11855887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine papillary serous carcinoma: patterns of metastatic spread.
    Goff BA; Kato D; Schmidt RA; Ek M; Ferry JA; Muntz HG; Cain JM; Tamimi HK; Figge DC; Greer BE
    Gynecol Oncol; 1994 Sep; 54(3):264-8. PubMed ID: 8088602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous metastasis of papillary serous uterine cancer.
    Elit L; Lukka H; Friedman E
    Gynecol Oncol; 2001 Jul; 82(1):208-11. PubMed ID: 11426989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN).
    Goldberg H; Miller RC; Abdah-Bortnyak R; Steiner M; Yildiz F; Meirovitz A; VillĂ  S; Poortmans PM; Azria D; Zidan J; Ozsahin M; Abacioglu U; Gold DG; Amit A; Lavie O; Atahan IL; Kuten A;
    Gynecol Oncol; 2008 Feb; 108(2):298-305. PubMed ID: 18096209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplification of c-erbB2 oncogene: a major prognostic indicator in uterine serous papillary carcinoma.
    Santin AD; Bellone S; Van Stedum S; Bushen W; Palmieri M; Siegel ER; De Las Casas LE; Roman JJ; Burnett A; Pecorelli S
    Cancer; 2005 Oct; 104(7):1391-7. PubMed ID: 16116605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous metastasis of uterine papillary serous carcinoma.
    Kim ES; Lee DP; Lee MW; Choi JH; Moon KC; Koh JK
    Am J Dermatopathol; 2005 Oct; 27(5):436-8. PubMed ID: 16148416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uterine papillary serous carcinoma: patterns of failure and survival.
    Wang W; DO V; Hogg R; Wain G; Brand A; Bull C; Stenlake A; Gebski V
    Aust N Z J Obstet Gynaecol; 2009 Aug; 49(4):419-25. PubMed ID: 19694700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical aspects of uterine papillary serous carcinoma.
    Hamilton CA; Kapp DS; Chan JK
    Curr Opin Obstet Gynecol; 2008 Feb; 20(1):26-33. PubMed ID: 18197002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re: Uterine papillary serous carcinoma: patterns of metastatic spread.
    Thomas GM
    Gynecol Oncol; 1995 Jun; 57(3):437-8. PubMed ID: 7774855
    [No Abstract]   [Full Text] [Related]  

  • 12. Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer.
    Santin AD; Diamandis EP; Bellone S; Soosaipillai A; Cane S; Palmieri M; Burnett A; Roman JJ; Pecorelli S
    Clin Cancer Res; 2005 May; 11(9):3320-5. PubMed ID: 15867230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of kallikrein 10 (hK10) in uterine serous papillary carcinomas.
    Santin AD; Diamandis EP; Bellone S; Marizzoni M; Bandiera E; Palmieri M; Papasakelariou C; Katsaros D; Burnett A; Pecorelli S
    Am J Obstet Gynecol; 2006 May; 194(5):1296-302. PubMed ID: 16647913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uterine papillary serous carcinoma in a 32-year-old with Turner's syndrome.
    Woolas RP; Williams K; McCartney AJ
    Gynecol Oncol; 1994 Mar; 52(3):395-401. PubMed ID: 8157198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiation.
    Kelly MG; O'Malley D; Hui P; McAlpine J; Dziura J; Rutherford TJ; Azodi M; Chambers SK; Schwartz PE
    Gynecol Oncol; 2004 Dec; 95(3):469-73. PubMed ID: 15581948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of adjuvant therapy on survival of patients with early-stage uterine papillary serous carcinoma.
    Hamilton CA; Liou WS; Osann K; Berman ML; Husain A; Teng NN; Kapp DS; Chan JK
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):839-44. PubMed ID: 16199314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rare form of extraovarian peritoneal serous papillary carcinoma with solitary tumor in the abdominal wall: a case report and literature review.
    Matsuura T; Sugihara K; Kohmura Y; Sugimura H; Kanayama N
    J Obstet Gynaecol Res; 2009 Dec; 35(6):1142-7. PubMed ID: 20144179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic uterine serous carcinoma originating in an endometrial polyp: a report of 2 cases.
    Childs AJ; Burke JJ; Perry MY; Gallup DG
    J Reprod Med; 2005 Mar; 50(3):209-12. PubMed ID: 15841935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uterine papillary serous carcinoma: what have we learned over the past quarter century?
    Goff BA
    Gynecol Oncol; 2005 Sep; 98(3):341-3. PubMed ID: 16111527
    [No Abstract]   [Full Text] [Related]  

  • 20. Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy.
    Kelly MG; O'malley DM; Hui P; McAlpine J; Yu H; Rutherford TJ; Azodi M; Schwartz PE
    Gynecol Oncol; 2005 Sep; 98(3):353-9. PubMed ID: 16005947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.